Introduction {#s1}
============

Hypertension has become a growing public health concern, particularly in developing countries, with an estimated prevalence of 37.3%, in comparison with 22.9% in industrialized nations.^1^ Projections are that by the year of 2025, 75.0% (or 1.17 billion people) of the people with hypertension in the world will be living in emerging nations [@pone.0048255-Kearney1].

Although hypertension has been recognized as a major risk factor for cardiovascular morbidity and mortality worldwide, there are lacking nationwide prevalence data in most emerging countries [@pone.0048255-Mittal1], [@pone.0048255-Lewington1]. Such information is needed in order to determine the economic burden of hypertension, as well as to optimize health resources allocation toward improvement on its detection, treatment and control. In Brazil, many population-based surveys, representative of cities and of one state, have been done in the last three decades, but there is no estimate of prevalence for the whole country or of trends in this period. Hence, our study aimed to estimate the prevalence trends of hypertension in the adult Brazilian population through a systematic review with meta-analysis of population-based studies.

Methods {#s2}
=======

Study Designs and Eligibility Criteria {#s2a}
--------------------------------------

The eligibility criteria included population-based cross-sectional or cohort studies among participants aged 18 years or older, from 1980 to 2010. Studies with pregnant women were not included.

Studies with duplicate data were excluded. Population-based studies that addressed only specific socioeconomic strata (such as low-income individuals, or certain industry workers) were not considered representative of its geographical (city, State, or region) population and, therefore, deemed ineligible. Studies that assessed only secondary hypertension, or used samples originated from sources other than the general geographical population (i.e. not population-based) were also excluded.

Information Sources {#s2b}
-------------------

The search of the published literature was conducted in the electronic databases of PubMed, Embase, LILACS (Latin American and Caribbean Health Sciences Literature), and Scielo (Scientific Electronic Library Online) using MeSH terms and Entrees for PubMed e Embase, and DeCS (Health Sciences Descriptors) for the other two databases. Data that were not formally published were additionally searched in PhD theses and Master's dissertations registered in the electronic database of the Coordination for the Improvement of Higher Education Personnel (CAPES), Ministry of Education, Brazil. Annals of national and regional scientific sessions of Cardiology in Brazil were searched to identify studies presented only in these meetings. Full-text version of all potentially relevant articles, theses, or dissertation were downloaded from electronic databases or requested directly to the authors via e-mail.

Searching {#s2c}
---------

All searches were carried out independently by two reviewers. Search strategies were tested with the key words "hypertension", "prevalence", "statistics", and "Brazil", using the Boolean operator "OR", which retrieved tens of thousands of records. A second attempt was carried out in the same databases using the operator "AND". The following search strategies were used on PubMed: ("Hypertension"\[Majr\] AND "Prevalence") AND "Brazil" limited to all adults (≥19 years-old), and ("Hypertension/epidemiology"\[Majr\] OR "Hypertension/statistics and numerical data"\[Majr\]) AND "Brazil" limited to all adults (≥18 years-old). Only searches on PubMed and Embase were filtered for studies conducted in adults. No language restriction was applied. Independent manual search on reference lists of retrieved articles was also undertaken.

Study Selection and Data Collection {#s2d}
-----------------------------------

The first screening was based on a double-screening of titles and abstracts. Results which met explicit exclusion criteria were excluded. In the second step, the remaining manuscripts were assessed for full-text reading. In case of disagreement among reviewers, a third reviewer assessed the study and a decision for inclusion was reached by consensus. Data were entered in a pre-tested Microsoft Office Excel™ spreadsheet that was designed based on the Strengthening the Reporting of Observational Studies in Epidemiology Statement (STROBE) checklist [@pone.0048255-vonElm1]. Items 4, 5, 6a, 7--10, 12c--e, 13a, 14b, 16a, and 17 of the STROBE checklist were taken into account for the development of the data extraction spreadsheet.

Hypertension prevalence was the main summary measure used in this systematic review, which was extracted from studies using different definitions, that comprised four diagnostic criteria: blood pressure (BP) ≥140/90 mmHg or use of BP lowering medication (BPLM) (hereafter the JNC criteria - according to the Fourth to Seventh Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure); BP≥160/95 mmHg or use of BPLM (henceforward former World Health Organization (WHO) criteria, employed in older studies); self-reported hypertension through home visits, and self-reported hypertension through telephone inquiries [@pone.0048255-Chobanian1], [@pone.0048255-Report1]. Many studies with measured blood pressure presented estimates for the former WHO and JNC criteria, but older studies presented only for the former WHO criteria. Hypertension control rate was defined as the proportion of subjects with hypertension using BPLM and normal BP over the total number of subjects with hypertension on treatment.

Assessment of Study Quality and Risk of Bias {#s2e}
--------------------------------------------

All studies were assessed for selection and measurement biases as well as bias in the data analysis based on guidelines of the MOOSE checklist [@pone.0048255-Stroup1]. Selection biases were characterized by refusals to participate in the study of 20% or higher, description of a non-random sampling, the use of other than a random process for participants recruitment, and data collection made through telephone interviews, since it covers participants of higher socioeconomic level. Measurement biases were defined considering the type of device used for blood pressure measurement, the discard of the first measurement, except for studies that used self-reported hypertension or the report of lacking impact in the analysis. Bias in the analysis was considered possible if the design effect was not taken into account in calculating the prevalence of hypertension. All biases were dealt with sensitivity analyses, defined *a priori*, using the abovementioned factors stratified for diagnostic criteria and decade (e.g. oscillometric *vs.* all devices, according to JNC criteria in the 2000's; studies adjusted to design effect *vs.* all studies, according to the former WHO criteria in the 1980's; etc.). Also, a sensitivity analyses comparing the overall prevalence of hypertension, according to the JNC criteria in the 2000's, versus the pooled prevalence without studies carried out exclusively in rural populations or studies that did not investigated elderly individuals was performed.

Data Analysis {#s2f}
-------------

All point estimates of analyses and their 95% confidence interval (95% CI) were calculated using random effects models according to decade, sex (when possible), and hypertension definition. The random effects model, wherein the weight study is inversely proportional to the sum of the variation within and between study studies of variance (T2) allows one to study the variance is diluted in variance between studies. Therefore, study variance impact on study weight is considerably diminished, and so is the influence of individual studies weights to the model as a whole. Nevertheless, the analyses using fix effect models were also tested, resulting in identical point estimates, but with narrower confidence intervals (data not shown).

Subgroup analyses included overall prevalence of hypertension according to the JNC criteria by decade, analyses by macro-region and design effect correction in the 2000's, and control rates from 1980 to 2010 by decade. Heterogeneity and consistency were evaluated through Cochran's *Q* and the *I^2^* statistics, respectively. Analyses were performed using the second version of the Comprehensive Meta-Analysis™ software. Forest plots were constructed using an electronic spreadsheet developed by Neyeloff et al [@pone.0048255-Neyeloff1].

Chi-square (χ^2^) was used to assess difference in prevalence rates among two distinct decades. Chi for trend (χ for trend) was used to evaluate prevalence and control rate across the three decades. Meta-regression -- regressing the year of data collection and local human development index (HDI) on the logit prevalence rate -- was employed to assess the prevalence variation throughout the studied period, using the method of moments for the estimation of tau-squared (τ^2^, i.e. between-study variance).

The Institution Review Board, which is accredited by the US Office of Human Research Protections, approved the research protocol.

Results {#s3}
=======

Synthesis of Data {#s3a}
-----------------

Through the searches, 761 articles were found in the electronic databases (51 being theses/dissertations published in the CAPES's database), one study published by some of the authors was further analyzed to provide data, and other six articles retrieved by manual search -- totalizing 600 initial records after removal of duplicates [@pone.0048255-Trevisol1]. Manual search of the Annals of Cardiology meetings identified only studies already found in other sources. The first screening excluded 444 records and the second screening, another 108. By consensus with the third reviewer another eight studies were excluded, leaving 40 studies with 122018 individuals for the analysis. Agreement among reviewers for individual selection of studies was 78%, and after consensus meetings it reached 100%. Flowchart of studies selection is presented in [Figure 1](#pone-0048255-g001){ref-type="fig"}. The list of studies included and excluded in the meta-analysis, and the reasons for exclusion, are presented in [Table S1](#pone.0048255.s001){ref-type="supplementary-material"}.

![Flowchart of records retrieved, screened and included in the systematic review.](pone.0048255.g001){#pone-0048255-g001}

[Table 1](#pone-0048255-t001){ref-type="table"} presents the overall characteristics of the 40 studies. Prevalence rates and their 95% CI by decade, diagnostic criteria, and method of assessment (measured or self-reported) are presented in [Table 2](#pone-0048255-t002){ref-type="table"}. Summary estimates according to the former WHO criteria (BP≥160/95 mmHg or BPLM) in the 1980's and 1990's were 23.6% (95% CI 17.3--31.4%) and 19.6% (16.4--23.3%), respectively. In the 2000's, the pooled prevalence estimates of self-reported hypertension on telephone inquiries was 20.6% (19.0--22.4%), and of self-reported hypertension in home surveys was 25.2% (23.3--27.2%).

10.1371/journal.pone.0048255.t001

###### Source, year, sample size and methodological aspects of the 40 studies included in meta-analysis (in alphabetical order of first author).

![](pone.0048255.t001){#pone-0048255-t001-1}

  First author                Source or database           Year of data collection     N     Age criterion for study entry (years)    City, State, or region     Devices used and hypertension assessment method   BP cut-off value for hypertension (SBP/DBP in mm Hg)
  ------------------- ----------------------------------- ------------------------- ------- --------------------------------------- --------------------------- ------------------------------------------------- ------------------------------------------------------
  Costa VG                          LILACS                          1982             1200                   18--80                          Uberlândia                        Device not described                                        160/95
  de Lolio CA                   PubMed & LILACS                     1987             1199                   15--74                          Araraquara                               Aneroid                                         140/90 & 160/95
  Martins IS            Embase, LILACS, PubMed & Scielo             1987             1041                     ≥20                              Cotia                              Mercury & SRH                                      140/90 & 160/95
  Ayres JE                           PuMed                          1988             1944                     ≥15                           Piracicaba                        Device not described                                        160/95
  Fuchs FD                  Embase, PubMed & LILACS                 1989             1091                     ≥18                          Porto Alegre                        Aneroid, BPLM & SRH                                   140/90 & 160/95
  Bloch KV                  Embase, PubMed & LILACS                 1991             1268                     ≥20                       Rio de Janeiro city                      Mercury & BPLM                                           160/95
  Piccini RX            Embase, LILACS, PubMed &Scielo              1992             1657                   20--69                            Pelotas                          Aneroid, BPLM & SRH                                        160/95
  Trindade IS           Embase, LILACS, PubMed & Scielo             1995              206                     ≥18                           Passo Fundo                        Aneroid, BPLM & SRH                                        160/95
  Fuchs SC^‡^               Embase, PubMed & LILACS                 1996             1174                     ≥18                          Porto Alegre                           Aneroid & SRH                                           140/90
  Barreto SM            Embase, LILACS, PubMed & Scielo             1997              820                   18--59                            Bambuí                              Mercury & SRH                                           140/90
  de Oliveira RZ                Embase & LILACS                     1998              411                   20--69                           Cianorte                          Mercury, BPLM & SRH                                   140/90 & 160/95
  Freitas OC            Embase, LILACS, PubMed & Scielo             1998              688                     ≥18                            Catanduva                               Aneroid                                              140/90
  da Costa JSD                 LILACS & CAPES-TD                    1999             1968                   20--69                            Pelotas                            Aneroid & BPLM                                           160/95
  Gus I                         LILACS & Scielo                     1999             1063                     ≥20                    Rio Grande do Sul (state)                No description & SRH                                   140/90 & 160/95
  Lessa I               Embase, LILACS, PubMed & Scielo             1999             1439                     ≥20                            Salvador                         Oscillometric & BPLM                                        140/90
  First author                Source or database           Year of data collection     N     Age criterion for study entry (years)    City, State, or region     Devices used and hypertension assessment method   BP cut-off value for hypertension (SBP/DBP in mm Hg)
  Mill JG                Article references & CAPES-TD              1999             1656                   25--64                            Vitória                            Mercury & BPLM                                           140/90
  Gimeno SGA                        Embase                          2000              201                     ≥20                           Alto Xingu                          Aneroid & Mercury                                         140/90
  de Souza LJ                       LILACS                          2001             1039                     ≥18                      Campos dos Goytacazes                   Aneroid &, BPLM SRH                                        140/90
  INCA\*\*                     Article reference                    2002             17059                    ≥25                           18 Capitals                                SRH                                            Not applicable
  Jardim PCBV           Embase, LILACS, PubMed & Scielo             2002             1739                     ≥18                             Goiânia                         Oscillometric & BPLM                                        140/90
  Barbosa JB            Embase, LILACS, PubMed & Scielo             2003              835                     ≥18                            São Luís                            Aneroid & BPLM                                           140/90
  Capilheira MF                     LILACS                          2003             3100                     ≥20                             Pelotas                                  SRH                                            Not applicable
  Cassanelli T                     CAPES-TD                         2003             1699                   18--74                            Cuiabá                       Device not described & BPLM                                    140/90
  de Souza JJG                 LILACS & CAPES-TD                    2003             1667                     ≥20                         São Paulo city                               SRH                                            Not applicable
  Hartmann M           PubMed, LILACS, Scielo & CAPES-TD            2003             1020                   20--60                         São Leopoldo                          Aneroid & BPLM                                           140/90
  Matos AC                          LILACS                          2003              126                     ≥19                             Cavunge                            Aneroid & BPLM                                           140/90
  Monteiro CA\*               Article references                    2003             2122                     ≥18                         São Paulo city                               SRH                                            Not applicable
  Carvalhaes MABL\*                 LILACS                          2004             1410                     ≥18                            Botucatu                                  SRH                                            Not applicable
  Cesarino CB                   LILACS & Scielo                     2004             1717                     ≥18                      São José do Rio Preto               Device not described & BPLM                                    140/90
  de Castro RA          Embase, LILACS, PubMed & Scielo             2004              285                     ≥18                             Formiga                             Oscillometric                                           140/90
  First author                Source or database           Year of data collection     N     Age criterion for study entry (years)    City, State, or region     Devices used and hypertension assessment method   BP cut-off value for hypertension (SBP/DBP in mm Hg)
  Borges HP\*               Embase, LILACS & Scielo                 2005             2352                     ≥18                              Belém                                   SRH                                            Not applicable
  Fuchs SC^†^                  Article reference                    2005             1007                     ≥18                          Porto Alegre                     Oscillometric, BPLM & SRH                                     140/90
  Peixoto MRG\*                     LILACS                          2005             2002                     ≥18                             Goiânia                                  SRH                                            Not applicable
  SOFT study               Directly from the author                 2005             1858                   18--90                         Porto Alegre                       Oscillometric & BPLM                                        140/90
  Ferreira SRHG\*                   Pubmed                          2006             54369                    ≥18                    Brasília & state capitals                         SRH                                            Not applicable
  Nunes Filho JR                    LILACS                          2006              353                   20--59                            Luzerna                          Aneroid, BPLM & SRH                                        140/90
  Rosário TM               LILACS, Scielo & CAPES-TD                2006             1003                   18--90                            Nobres                              Oscillometric                                           140/90
  Braga Junior FD                  CAPES-TD                         2007             1298                   20--59                            Cuiabá                          Device not described                                        140/90
  Chrestani MAD            LILACS, Scielo & CAPES-TD                2007             2910                     ≥20                             Pelotas                    Wrist Oscillometric, BPLM & SRH                                  140/90
  Longo GZ                          Scielo                          2007             2022                   20--59                             Lages                          Oscillometric & BPLM                                        140/90

10.1371/journal.pone.0048255.t002

###### Meta-analysis of observational studies: prevalence rate of hypertension by decade and adjustment to the design effect, including 12 2018 individuals.

![](pone.0048255.t002){#pone-0048255-t002-2}

  Decade    Hypertension criteria (number of studies/number of adjusted studies)   Prevalence rate (95% CI)   Adjusted *vs.* unadjusted[\*](#nt102){ref-type="table-fn"}                                          
  -------- ---------------------------------------------------------------------- -------------------------- ------------------------------------------------------------ ------------------- ------------------- ---------
  1980's                               WHO (n = 5/1)                                  21.6 (14.9--30.2)                           18.0 (11.3--27.4)                        23.6 (17.3--31.4)   31.3 (28.6--34.2)   \<0.001
                                       JNC (n = 3/2)                                  45.1 (40.0--50.4)                           34.6 (23.7--47.5)                        36.1 (28.7--44.2)   36.7 (24.4--51.0)    0.57
  1990's                               WHO (n = 6/0)                                  20.3 (17.0--24.1)                           20.02 (14.4--27.6)                       19.6 (16.4--23.3)          --             --
                                       JNC (n = 8/0)                                  29.7 (22.5--38.2)                           27.2 (19.9--36.1)                        32.9 (29.9--36.0)          --             --
  2000's                    Self-report in home visit (n = 4/2)                       15.8 (11.7--21.0)                           23.4 (16.6--31.9)                        25.2 (23.3--27.2)   20.0 (14.4--27.1)   \<0.001
                      Self-report through telephone inquiry (n = 5/4)                 18.6 (17.4--19.9)                           23.2 (21.1--25.4)                        20.6 (19.0--22.4)   21.4 (20.3--22.6)    0.51
                                       JNC (n = 14/4)                                 27.3 (22.5--32.8)                           27.7 (23.7--32.0)                        28.7 (26.2--31.4)   30.7 (26.6--35.1)    0.07

  Decade                 Hypertension criteria (number of studies)                 χ^2^ (P value)                                                                                                             
  --------------------- ------------------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- -- --
  1980's *vs.* 1990's                  WHO (n = 11)                                     0.33                                         0.10                                       \<0.001                       
  1980's *vs.* 1990's                  JNC (n = 11)                                   \<0.001                                      \<0.001                                        0.02                        
  1980's *vs.* 2000's                  JNC (n = 17)                                   \<0.001                                       0.006                                       \<0.001                       
  1980's to 2000's                     JNC (n = 25)                  \<0.001[\*\*](#nt103){ref-type="table-fn"}   \<0.001[\*\*](#nt103){ref-type="table-fn"}   \<0.001[\*\*](#nt103){ref-type="table-fn"}     

WHO = World Health Organization diagnostic criteria; JNC = Joint National Committee diagnostic criteria; 95% CI = 95% confidence interval.

P value for χ^2^.

P value for χ for trend.

Prevalence of hypertension by the former WHO criteria in older studies was obviously lower than the prevalence by the JNC criteria. Self-reported hypertension, either at home or by telephone interview (mostly previous doctor's diagnoses), yielded lower prevalence rates as well. Prevalence rates were roughly similar among men and women and did not change substantially in studies with adjustment for the design effect or using different blood pressure devices. Heterogeneity was present in all the pooled estimates shown in [Table 2](#pone-0048255-t002){ref-type="table"} (P\<0.001 and *I^2^*\>90.0% for every analyses).

Prevalence rates according to the JNC criteria in individual studies, summary estimates by decade, and overall pooled rate are presented in [Figure 2](#pone-0048255-g002){ref-type="fig"}. The prevalence decreased by decades: 36.1% (28.7--44.2) in the 1980's, 32.9% (29.9--36.0) in the 1990's, and 28.7 (26.2--31.4) in the 2000's (P for trend \<0.001). The estimated prevalence for the past three decades (according to the JNC criteria) was 31.0%, with 95% CI from 29.1 to 32.9%. With the exception of the North macro-region, which had estimates of prevalence exclusively from the Alto Xingu Indian population, the prevalence was similar among the various Brazilian macro-regions ([Figure 3](#pone-0048255-g003){ref-type="fig"}).

![Prevalence of hypertension, according to the JNC criteria, by decade.](pone.0048255.g002){#pone-0048255-g002}

![Prevalence of hypertension, according to the JNC criteria, by Brazilian macro-region in the 2000's.](pone.0048255.g003){#pone-0048255-g003}

In the 2000's, pooled prevalence rate for studies adjusted for the design effect did not differ from all studies (adjusted and unadjusted) according to the JNC criteria (χ^2^ P = 0.07) and telephone inquiries (P = 0.51). The meta-regression of year of data collection over logit prevalence confirmed a trend toward decreasing in prevalence from 1987 to 2007, with a slope of −0.018 (P = 0.02). Furthermore, a τ^2^ = 0.05 was found, which means that differences in the year of data collection explain 90.2% of the between-studies variance ([Figure 4](#pone-0048255-g004){ref-type="fig"}).

![Regression of first year of data collection on logit prevalence rate according to the JNC criteria.](pone.0048255.g004){#pone-0048255-g004}

Meta-regression of year of data collection over logit prevalence according to sex showed a non-significant slope of −0.012 (P = 0.42) for women, and a significant slope of −0.035 (P = 0.02) for men (τ^2^ = 0.11; explained between-studies variance of 79.2%) (data not shown). Meta-regression of HDI on logit prevalence (according to 2000 HDI for each city) retrieved a non-significant slope of 1.070 (P = 0.42) (data not shown). Additionally, control rates were properly reported in 10 studies and pooled rates, according to the JNC criteria, were 33.8% (26.0--42.6%), 28.1% (23.7--32.7%), and 24.1% (10.1--47.3%) in the 1980's, 1990's and the 2000's, respectively (χ^2^ for trend p\<0.001).

Assessing Bias {#s3b}
--------------

All studies were cross-sectional, and there was moderate (59.0%) overlap of records across different databases. Five studies (12.5%) were from the 1980's, 11 (27.5%) from the 1990's and 24 (57.5% to 60.0%) from 2000's. Sample sizes varied substantially with a median of 1268 (IQR 838.5). Most studies that measured blood pressure employed aneroid or mercury manometers (18 studies), and eight used oscillometric manometers. Almost all studies were from urban populations (37 studies), and mostly were done in the South and Southeast macro-regions of Brazil ([Figure 5](#pone-0048255-g005){ref-type="fig"}). In regard to methodological features of the studies, 33 used multistage cluster sampling, six used simple random sampling, and the study by Gimeno et al. evaluated 90% of the adults of Alto Xingu's native Brazilian \]10\]. Most studies (n = 25; 62.5%) did not have selection bias with potential to compromise their internal validity. Fourteen (35.0%) studies had sampling or sample size calculation poorly described. Only one study had high rate of missing data. In 10 studies the first measurement was discarded. Twelve (30.0%) studies, mostly done in the 2000's, presented data adjusted for design effect. [Table S1](#pone.0048255.s001){ref-type="supplementary-material"} presents data on potential selection and measurement biases, as well as bias in the analysis.

![Map of Brazil according to its five macro-regions with the cities comprehended in the meta-analysis.](pone.0048255.g005){#pone-0048255-g005}

Sensitivity analyses were carried out excluding studies conducted in rural areas (n = 3), studies that did not investigate elderly individuals (n = 2), studies that employed oscillometric wrist manometer (n = 1), and one with a small sample size [@pone.0048255-Longo1]--[@pone.0048255-Castro1]. The overall prevalence for the decade did not altered significantly (30.8%; 95%CI: 27.8--34.0%). All other sensitivity analyses defined *a priori* (see Assessment of study quality and risk of bias) showed similar results with no statistically significant differences (data not shown).

Discussion {#s4}
==========

In this comprehensive systematic review with meta-analysis of cross-sectional surveys done in Brazil in the last three decades, including more than 120 thousand individuals, it was possible to compute precise estimates of prevalence by decade, by criteria of definition of hypertension, by methods of diagnosing hypertension, and by gender. Overall, the prevalence was similar to described in developed countries, particularly of hypertension diagnosed by blood pressure measurement and based on the contemporaneous universal criteria for diagnosis of hypertension, and without any substantial differences by gender [@pone.0048255-Kearney1], [@pone.0048255-Kearney2]. An apparent trend to lowering in prevalence by decade was evident. The proportion of one-third of hypertensive individuals with controlled blood pressure is also within the range of rates of control described worldwide [@pone.0048255-Whelton1].

Our study could circumvent many limitations of individuals studies selected for the meta-analysis of Danaei et al, such as regional inequities [@pone.0048255-Danaei1]. Furthermore, Danaei et al employed mean systolic blood pressure to describe trends of risk, an approach that does not take into account the real number of subjects at risk. The potential reasons for bias in the whole estimates are the overrepresentation of studies done in metropolitan populations, particularly from the South and Southeast macro-regions of the country. Nonetheless, 84.4% of the Brazilian population lives nowadays in cities [@pone.0048255-Instituto1]. The absence of representative data from the North macro-region was partially overcome by the inclusion of a study of native Brazilians. On the other hand, the North macro-region, although has the largest area, has the lowest density in the country, comprising 50% of Brazil's land territory, but only 5% of the country's population [@pone.0048255-Instituto1]. A few studies enrolled subjects below the age range, but the analysis with and without those studies did not change substantially the overall estimates.

Prevalence rates based on direct measurement of blood pressure were higher than those based on self-report hypertension [@pone.0048255-Bowlin1]--[@pone.0048255-Giles1]. The lower prevalence in telephone surveys may additionally be secondary to the differential distribution of telephones by social classes, leading to an underrepresentation of individuals from lower classes, who had higher prevalence of hypertension [@pone.0048255-Bowlin2], [@pone.0048255-Segri1]--[@pone.0048255-Fuchs1].

Most studies did not take into account the distortions caused by multistage and weighting sampling. The lack of adjustment for design effect can compromise accuracy of prevalence confidence intervals for individual studies and, consequently, making the results of older surveys less reliable than those done in the last decade [@pone.0048255-Guilln1], [@pone.0048255-Office1]. Nevertheless, the comparison between studies with and without adjustment for sampling design showed that the former provided reliable estimates.

The average absolute reduction in prevalence of 3.7% per decade is consistent with recent meta-analysis that found a mean 1.8 and 3.5 mmHg decrease per decade in systolic blood pressure for males, and females, respectively, from 1980 to 2008 [@pone.0048255-Report1]. Also, meta-regression showed a slight, but steady relative reduction in prevalence of 1.8% per year from 1987 to 2007. This trend reproduces the estimates observed in industrialized nations, confirming that the epidemiological transition already finished in Brazil in regard to hypertension. Significant reduction in prevalence among men and non-significant reduction in women might suggest that the overall prevalence decrease had a greater impact in men.

The trend toward reduction of the control rate was contrary to expectations. Increase in detection of hypertension and of the access to BPLM in the Brazilian Health System (universal coverage and free of charge), in the 1990's. Hence, the number of subjects on treatment for hypertension might have augmented proportionally more than the number of subjects with controlled hypertension in the last two decades. It might give the false impression that fewer subjects are keeping their blood pressure below 140/90 mm Hg. Nonetheless, the pooled estimate of control rate is consistent with the literature [@pone.0048255-Pereira1].

Despite the heterogeneity of studies, lack of adjustment for effect design in many studies, and underrepresentation of the population from the North macro-region, the estimates are reliable and within the range of prevalence described for industrialized nations. The trend for lowering in the prevalence rates by decade follows the pattern of industrialized countries as well. The proportion of individuals with controlled hypertension, of about one-third of individuals, is similar to the described in other countries, and it requires innovative and effective means to improve the rates of control.

This pooled analysis of prevalence of hypertension is an attempt to fill the lack of national data. However, the estimates of prevalence of hypertension not adequately represent the Brazilian Indians, the rural population, and those living in the vicinity of the Amazon rainforest. This study presents data for the most populated areas of Brazil, as can be seen in the Brazil map ([Figure 5](#pone-0048255-g005){ref-type="fig"}). Therefore, the results are not a substitute for a nationwide prevalence study. Therefore, the results are not a substitute for a national prevalence study. However, until this study be conducted, these analyzes are the best estimates available that can serve as a reference for public health policy [@pone.0048255-Tomson1].

Conclusions {#s4a}
-----------

As such, this meta-analysis was an alternative way to establishing the hypertension prevalence in Brazil, which is necessary to assess the hypertension burden and to implement cost-effective interventions. Nonetheless, a nationwide prevalence study is still needed to confirm the estimates and determine more accurate rates for specific populations.
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